Atypical Hyperplasia: 61 Clinical Trials, Page 1 of 7

1 2 3 4 5 … »Last Page »

Hide Studies Not Open or Pending

Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma

Condition(s):Endometrial Atypical Hyperplasia; Endometrial AdenocarcinomaLast Updated:October 30, 2017Completed

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ

Condition(s):Atypical Hyperplasia; Lobular Carcinoma in SituLast Updated:October 8, 2020Not yet recruiting

Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

Condition(s):Complex Atypical Hyperplasia; Endometrial CancerLast Updated:July 2, 2020Recruiting

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium

Condition(s):Endometrial Cancer; Atypical Hyperplasia; Bariatric Surgery CandidateLast Updated:March 25, 2020Not yet recruiting

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

Condition(s):Atypical Endometrial HyperplasiaLast Updated:June 18, 2020Completed

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

Condition(s):Atypical Hyperplasia; Endometrial Intraepithelial Neoplasia; FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid AdenocarcinomaLast Updated:December 14, 2020Recruiting

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer

Condition(s):Atypical Endometrial Hyperplasia; FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid AdenocarcinomaLast Updated:July 23, 2020Recruiting

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

Condition(s):Atypical Endometrial Hyperplasia; Stage I Uterine Corpus Cancer AJCC v7; Stage IA Uterine Corpus Cancer AJCC v7; Stage IB Uterine Corpus Cancer AJCC v7; Stage II Uterine Corpus Cancer AJCC v7Last Updated:January 2, 2020Active, not recruiting

Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

Condition(s):Atypical Endometrial Hyperplasia; Obese; Fertility IssuesLast Updated:December 24, 2020Not yet recruiting

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

Condition(s):Atypical Hyperplasia of the Breast; Lobular Breast Carcinoma In Situ; Pleomorphic Lobular Breast Carcinoma In SituLast Updated:January 7, 2021Recruiting

1 2 3 4 5 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.